English ticker view
BBIO
BRIDGEBIO PHARMA INC
This page combines public comments, SEC 13F holdings, insider trades, and simple return calculations for one ticker. Use the original source links before making your own decision.
Current price
$78.50
Public comments
0
13F holding rows
63
Insider trade rows
20
Public comments
0
Ranked by current return where prices are available.
13F direction
37 / 24
New or increased positions vs reduced or sold positions.
Insider activity
0 buyers
Based on SEC Form 4 market purchase and sale rows.
Latest comments
Most recent public records
SEC 13F
Institution holding changes
Nuveen Asset Management, LLC
decreased · Feb 14, 2025
+186.1%
Filing price $27.44 · Current $78.50
JPMorgan Chase & Co.
sold out · May 13, 2026
+13.2%
Filing price $69.36 · Current $78.50
Raymond James Financial Inc
increased · May 14, 2026
+9.6%
Filing price $71.61 · Current $78.50
Dimensional Fund Advisors LP
increased · May 7, 2026
+5.8%
Filing price $74.1617 · Current $78.50
Janus Henderson Group PLC
unchanged · May 18, 2026
+5.7%
Filing price $74.255 · Current $78.50
Optiver Holding B.V.
unchanged · May 15, 2026
+5.7%
Filing price $74.2597 · Current $78.50
Amundi
increased · May 15, 2026
+5.7%
Filing price $74.26 · Current $78.50
Massachusetts Financial Services Co
decreased · May 14, 2026
+5.7%
Filing price $74.26 · Current $78.50
Insider trades
SEC Form 4 summary
Market sells
6 owners
Rows
52
Estimated amount
$29,395,819.35
Average price $68.9458 · Latest Jun 24, 2026